Welcome to our dedicated page for Align Technology news (Ticker: $ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Align Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Align Technology's position in the market.
Rhea-AI Summary
Align Technology, Inc. announced a $150 million open market repurchase as part of its $1.0 billion stock repurchase program. The company aims to capitalize on its market opportunity while providing value to shareholders. The repurchases will be executed through a trading plan and funded with the company's existing cash. Align Technology remains confident in its ability to lead the orthodontic industry with its Invisalign® system.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.48%
Tags
-
Rhea-AI Summary
Align Technology reported strong financial results for the first quarter of 2024, with total revenues up 5.8% year-over-year, driven by growth in Clear Aligners and Imaging Systems. The company's operating income was $154.1 million, with a non-GAAP operating margin of 19.8%. Net income was $105.0 million, or $1.39 per diluted share, and $161.4 million on a non-GAAP basis. Align achieved key milestones during the quarter, including acquisitions, product launches, and regulatory approvals. The company also announced a new advertising campaign for the Invisalign brand and received favorable legal judgments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.05%
Tags
-
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) launches the 'Better Way' campaign for the Invisalign Palatal Expander System, highlighting its effectiveness, safety, and comfort compared to traditional metal expanders. The campaign targets parents, emphasizing the benefits of the innovative 3D-printed appliance for children's orthodontic treatment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
Rhea-AI Summary
Align Technology, Inc. announced the commercial availability of Invisalign Palatal Expanders in Australia and New Zealand, offering an innovative and customizable orthodontic solution for patients. The system, featuring 3D printed devices, is designed for early intervention treatment, catering to a wide range of patient demographics. With a focus on digital orthodontics, Align aims to enhance treatment efficiency and patient experience in the Asia Pacific region.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
-
Rhea-AI Summary
Align Technology, Inc. (ALGN) will report first quarter 2024 financial results on April 24, 2024, after market close. The company designs and sells Invisalign clear aligners, iTero intraoral scanners, and exocad CAD/CAM software. The financial results will be available on the Align website, followed by a conference call to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
-
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) has been included in the Intellectual Property Owners Association annual report of the top 300 organizations granted U.S. patents. In 2023, Align is at position #270, with 158 U.S. patents granted, a 36% increase compared to 2022. The patents cover technologies that revolutionize the field of orthodontics and digital dentistry. The recognition reflects Align's investment in developing next-generation devices and technology that provide what their doctor customers want and need for their patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
Rhea-AI Summary
Align Technology, Inc. (NASDAQ: ALGN) has announced the launch of the iTero Lumina™ intraoral scanner, powered by the new iTero Multi-Direct Capture™ technology. The scanner features a 3X wider field of capture in a 50% smaller and 45% lighter wand, delivering faster scanning speed, higher accuracy, superior visualization, and a more comfortable scanning experience. The iTero Lumina scanner is designed to capture more data, deliver exceptional scan quality, and remove the need for intraoral photos. It offers multi-angled scanning, a larger capture distance, and effortless scanning experience, setting a new standard in digital scanning technology. The launch aims to enhance clinical outcomes, increase practice efficiency, and deliver an elevated, more comfortable experience for clinicians and patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
-
Rhea-AI Summary
Align Technology, Inc. reported Q4 and FY2023 total revenues up 6.1% and 3.4% year over year, respectively. Major milestones include 17 million Invisalign patients, 4 million Vivera retainers, and 100 thousand iTero scanner units sold in 2023. The company's 2023 total revenues were $3.9 billion, with clear aligner revenues of $3.2 billion and systems and services revenues of $662.9 million. The 2023 operating margin was 16.7%, with non-GAAP operating margin of 21.4%. The company repurchased $600 million of common stock in 2023. Q4'23 total revenues were $956.7 million, down 0.4% sequentially and up 6.1% year-over-year. Clear Aligner revenues were $781.9 million, down 1.6% sequentially and up 6.9% year-over-year. The company also unveiled the iTero Lumina intraoral scanner with significant improvements in scanning capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.27%
Tags
-
Rhea-AI Summary
Align Technology, Inc. (ALGN) completes the acquisition of Cubicure GmbH, a pioneer in direct 3D printing solutions, to strengthen its 3D printed product portfolio. The acquisition will support and scale Align’s strategic innovation roadmap and extend its printing, materials, and manufacturing capabilities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
Rhea-AI Summary
Align Technology, Inc. (Nasdaq: ALGN) will report Q4 2023 financial results on January 31, 2024, after the market close. The financial results will be released at 4:00 p.m. ET and a conference call will follow at 4:30 p.m. ET. Tentative earnings release dates for fiscal 2024 have also been announced.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
Align Technology Inc
Nasdaq:ALGN
ALGN Rankings
ALGN Stock Data
21.57B
69.96M
6.54%
88%
1.87%
Surgical Appliance and Supplies Manufacturing
Manufacturing
United States of America
TEMPE
About ALGN
align technology is a global medical device company with industry-leading innovative products -- invisalign clear aligners and itero intraoral scanners -- that help dental professionals achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients. invisalign system invisalign clear aligners have been used to straighten teeth and treat minor to complex malocclusion for more than 3 million patients worldwide. the invisalign system is a combination of proprietary virtual modeling software and rapid mass-manufacturing processes used to develop a treatment plan and with custom-made aligners for each patient. invisalign is prescribed to patients through invisalign-trained orthodontists and general practitioner dentists (gp) and is offered in over 90 countries. learn more at www.invisalign.com itero intraoral scanner the itero scanner’s parallel confocal imaging technology uses optical and laser scanning to achieve a high level of precisi